Evidence map›Paper›PMID 38727317›Full record

ReviewCells2024

Nuclear mTOR Signaling Orchestrates Transcriptional Programs Underlying Cellular Growth and Metabolism.

Tinghan Zhao, Jialin Fan, Ahmed Abu-Zaid, Stephen K Burley, X F Steven Zheng

Abstract readReview
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tinghan ZhaoRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.ORCID 0000-0002-7674-8117
Jialin FanRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.ORCID 0000-0002-7048-3955
Ahmed Abu-ZaidRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
Stephen K BurleyRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
X F Steven ZhengRutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.

Funding

Oncogenic Chromatin Remodeling and Anticancer MechanismsR01CA280177 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI STEVEN ZHENG · 2023 to 2026
$1.8M
Metabolic Control and Anticancer MechanismR01CA260006 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI STEVEN ZHENG · 2021 to 2026
$1.7M
Amino Acids-Rab1A Nutrient Signaling in the Regulation of Glucose HomeostasisR01DK124897 · NIDDK · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ZHENG, STEVEN · 2020 to 2023
$1.5M
NIH HHS R01CA260006NIH HHS R01CA280177NIH HHS R01DK124897
6 · The paper itself

Abstract

mTOR is a central regulator of cell growth and metabolism in response to mitogenic and nutrient signals. Notably, mTOR is not only found in the cytoplasm but also in the nucleus. This review highlights direct involvement of nuclear mTOR in regulating transcription factors, orchestrating epigenetic modifications, and facilitating chromatin remodeling. These effects intricately modulate gene expression programs associated with growth and metabolic processes. Furthermore, the review underscores the importance of nuclear mTOR in mediating the interplay between metabolism and epigenetic modifications. By integrating its functions in nutrient signaling and gene expression related to growth and metabolism, nuclear mTOR emerges as a central hub governing cellular homeostasis, malignant transformation, and cancer progression. Better understanding of nuclear mTOR signaling has the potential to lead to novel therapies against cancer and other growth-related diseases.

Indexed as

Cell NucleusCell ProliferationSignal TransductionTOR Serine-Threonine KinasesAnimalsEpigenesis, GeneticHumansNeoplasmsTranscription, GeneticTOR Serine-Threonine Kinasesandrogen receptorARID1AcancercBAFchromatinchromatin remodelingepigeneticsgrowthhistone acetylationhistone methylationmetabolismmTORnucleusrapamycinsignalingtranscription

Identifiers

PMID38727317
PMCPMC11083943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.